ARTICLE | Distillery Therapeutics
Therapeutics: Activating transcription factor 4 (ATF4); heme oxygenase decycling 1 (HMOX1; HO-1; Hsp32)
June 18, 2015 7:00 AM UTC
Cell culture, mouse and patient sample studies suggest inhibiting ATF4 could help treat cancer. In patients with breast or sarcomal tumors, levels of ATF4 and the antioxidant protein HMOX1 were higher...